Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 10 | 2022 | 2736 | 1.000 |
Why?
|
| Analgesics, Opioid | 8 | 2022 | 3674 | 0.790 |
Why?
|
| Opioid-Related Disorders | 7 | 2022 | 2065 | 0.760 |
Why?
|
| Candidiasis, Vulvovaginal | 1 | 2020 | 25 | 0.740 |
Why?
|
| Abnormalities, Drug-Induced | 5 | 2021 | 317 | 0.740 |
Why?
|
| Fluconazole | 1 | 2020 | 146 | 0.710 |
Why?
|
| Live Birth | 2 | 2022 | 512 | 0.690 |
Why?
|
| Abortion, Spontaneous | 1 | 2022 | 544 | 0.600 |
Why?
|
| Gestational Age | 3 | 2022 | 3493 | 0.550 |
Why?
|
| Antifungal Agents | 1 | 2020 | 730 | 0.520 |
Why?
|
| Neonatal Abstinence Syndrome | 3 | 2022 | 109 | 0.470 |
Why?
|
| Pregnancy Complications | 7 | 2022 | 2861 | 0.470 |
Why?
|
| Narcotic Antagonists | 1 | 2018 | 562 | 0.450 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.410 |
Why?
|
| Benzodiazepines | 1 | 2018 | 1101 | 0.410 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2021 | 2026 | 0.410 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 4 | 2021 | 3658 | 0.370 |
Why?
|
| Buprenorphine | 1 | 2018 | 640 | 0.360 |
Why?
|
| Pregnancy | 18 | 2022 | 29144 | 0.350 |
Why?
|
| Algorithms | 6 | 2022 | 13881 | 0.350 |
Why?
|
| Ondansetron | 2 | 2020 | 90 | 0.330 |
Why?
|
| Antiemetics | 2 | 2020 | 177 | 0.310 |
Why?
|
| Drug Prescriptions | 4 | 2021 | 1637 | 0.290 |
Why?
|
| Cleft Palate | 3 | 2020 | 560 | 0.260 |
Why?
|
| Pregnancy Trimester, First | 4 | 2021 | 853 | 0.240 |
Why?
|
| Infant, Newborn | 11 | 2022 | 25625 | 0.230 |
Why?
|
| Managed Care Programs | 2 | 2019 | 950 | 0.220 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2022 | 2408 | 0.220 |
Why?
|
| Birth Certificates | 1 | 2022 | 67 | 0.220 |
Why?
|
| United States | 16 | 2022 | 69872 | 0.200 |
Why?
|
| Stillbirth | 1 | 2022 | 346 | 0.180 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2020 | 95 | 0.170 |
Why?
|
| Nausea | 2 | 2020 | 673 | 0.170 |
Why?
|
| Databases, Factual | 4 | 2022 | 7729 | 0.170 |
Why?
|
| Otitis Externa | 1 | 2018 | 19 | 0.170 |
Why?
|
| DiGeorge Syndrome | 1 | 2020 | 177 | 0.160 |
Why?
|
| Medical Record Linkage | 1 | 2019 | 284 | 0.150 |
Why?
|
| Drug Information Services | 1 | 2017 | 51 | 0.150 |
Why?
|
| Pregnancy Outcome | 3 | 2022 | 2795 | 0.150 |
Why?
|
| Drug Therapy | 1 | 2020 | 497 | 0.150 |
Why?
|
| Cleft Lip | 2 | 2020 | 478 | 0.150 |
Why?
|
| Plant Extracts | 1 | 2020 | 471 | 0.150 |
Why?
|
| Female | 26 | 2022 | 380194 | 0.140 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 412 | 0.140 |
Why?
|
| Risk | 4 | 2021 | 9687 | 0.130 |
Why?
|
| Administration, Oral | 2 | 2020 | 3913 | 0.130 |
Why?
|
| Psychotropic Drugs | 2 | 2019 | 894 | 0.130 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 707 | 0.130 |
Why?
|
| Fee-for-Service Plans | 1 | 2019 | 694 | 0.120 |
Why?
|
| Access to Information | 1 | 2017 | 320 | 0.120 |
Why?
|
| Delivery, Obstetric | 1 | 2020 | 906 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 2 | 2018 | 1148 | 0.110 |
Why?
|
| Drug Interactions | 1 | 2017 | 1460 | 0.110 |
Why?
|
| Prenatal Care | 1 | 2019 | 1092 | 0.100 |
Why?
|
| Young Adult | 10 | 2022 | 56430 | 0.100 |
Why?
|
| Diabetes, Gestational | 1 | 2021 | 1184 | 0.100 |
Why?
|
| Humans | 28 | 2022 | 744343 | 0.100 |
Why?
|
| Gynecology | 1 | 2017 | 513 | 0.100 |
Why?
|
| Adult | 16 | 2022 | 214055 | 0.100 |
Why?
|
| Drug Utilization | 1 | 2017 | 1183 | 0.100 |
Why?
|
| Drug Therapy, Combination | 2 | 2018 | 6489 | 0.090 |
Why?
|
| Obstetrics | 1 | 2017 | 658 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2021 | 2987 | 0.080 |
Why?
|
| Antipsychotic Agents | 1 | 2022 | 3057 | 0.080 |
Why?
|
| Mothers | 1 | 2019 | 2165 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2266 | 0.080 |
Why?
|
| Florida | 2 | 2019 | 435 | 0.070 |
Why?
|
| Adolescent | 7 | 2022 | 85781 | 0.070 |
Why?
|
| Pregnant Women | 2 | 2021 | 568 | 0.070 |
Why?
|
| Heart Defects, Congenital | 2 | 2020 | 4584 | 0.070 |
Why?
|
| Substance-Related Disorders | 2 | 2018 | 4258 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 14722 | 0.060 |
Why?
|
| Prevalence | 2 | 2018 | 15226 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 25043 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2017 | 3309 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 13989 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 5987 | 0.050 |
Why?
|
| Cohort Studies | 5 | 2022 | 40561 | 0.050 |
Why?
|
| Male | 11 | 2022 | 350118 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 7181 | 0.050 |
Why?
|
| Texas | 1 | 2019 | 392 | 0.040 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2021 | 615 | 0.040 |
Why?
|
| Prescriptions | 1 | 2021 | 387 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 11725 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2020 | 1420 | 0.040 |
Why?
|
| Methadone | 1 | 2019 | 306 | 0.040 |
Why?
|
| Middle Aged | 6 | 2022 | 213383 | 0.030 |
Why?
|
| Vomiting | 1 | 2018 | 636 | 0.030 |
Why?
|
| Polypharmacy | 1 | 2017 | 294 | 0.030 |
Why?
|
| Insurance Claim Review | 1 | 2019 | 720 | 0.030 |
Why?
|
| Risk Factors | 5 | 2019 | 72290 | 0.030 |
Why?
|
| Child | 4 | 2022 | 77709 | 0.030 |
Why?
|
| Data Mining | 1 | 2017 | 537 | 0.030 |
Why?
|
| Propensity Score | 1 | 2018 | 1781 | 0.030 |
Why?
|
| Age Factors | 2 | 2019 | 18370 | 0.020 |
Why?
|
| Tobacco Use Disorder | 1 | 2017 | 688 | 0.020 |
Why?
|
| Educational Status | 1 | 2019 | 2540 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2022 | 2494 | 0.020 |
Why?
|
| Urban Population | 1 | 2017 | 2021 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2022 | 10943 | 0.020 |
Why?
|
| Time Factors | 2 | 2022 | 40075 | 0.020 |
Why?
|
| Data Collection | 1 | 2017 | 3341 | 0.020 |
Why?
|
| Acute Disease | 1 | 2018 | 7149 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 2716 | 0.020 |
Why?
|
| Rural Population | 1 | 2017 | 2210 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 4256 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2018 | 77449 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 2838 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2021 | 4468 | 0.020 |
Why?
|
| Sex Factors | 1 | 2017 | 10397 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21746 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8388 | 0.010 |
Why?
|
| Incidence | 1 | 2019 | 20947 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 19905 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39050 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 23338 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 35136 | 0.010 |
Why?
|
| HIV Infections | 1 | 2021 | 16718 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 41006 | 0.010 |
Why?
|
Concepts
(119)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_